Literature DB >> 24214335

Drug-induced angioedema: experience of Italian emergency departments.

G Bertazzoni1, M T Spina, M G Scarpellini, F Buccelletti, M De Simone, M Gregori, V Valeriano, F R Pugliese, M P Ruggieri, M Magnanti, B Susi, L Minetola, L Zulli, F D'Ambrogio.   

Abstract

Acute angioedema represents a cause of admission to the emergency department requiring rapid diagnosis and appropriate management to prevent airway obstruction. Several drugs, including angiotensin-converting enzyme inhibitors (ACE-I), nonsteroidal anti-inflammatory drugs (NSAIDs) and oral antidiabetics, have been reported to induce angioedema. The aim of this prospective observational study conducted in a setting of routine emergency care was to evaluate the incidence and extent of drug-induced non-histaminergic angioedema in this specific clinical setting, and to identify the class of drugs possibly associated with angioedema. Patients admitted to seven different emergency departments (EDs) in Rome with the diagnosis of angioedema and urticaria were enrolled during a 6-month period. Of the 120,000 patients admitted at the EDs, 447 (0.37 %) were coded as having angioedema and 655 (0.5 %) as having urticaria. After accurate clinical review, 62 cases were defined as drug-induced, non-histaminergic angioedema. NSAIDs were the most frequent drugs (taken by 22 out of 62 patients) associated with the angioedema attack. Of the remaining patients, 15 received antibiotic treatment and 10 antihypertensive treatment. In addition, we observed in our series some cases of angioedema associated with drugs (such as antiasthmatics, antidiarrheal and antiepileptics) of which there are few descriptions in the literature. The present data, which add much needed information to the existing limited literature on drug-induced angioedema in the clinical emergency department setting, will provide more appropriate diagnosis and management of this potentially life-threatening adverse event.

Entities:  

Mesh:

Year:  2013        PMID: 24214335     DOI: 10.1007/s11739-013-1007-x

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  44 in total

1.  Transient small bowel angioedema due to intravenous iodinated contrast media.

Authors:  Xiu-Hua Hu; Xiang-Yang Gong; Peng Hu
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 2.  Hereditary angio-oedema.

Authors:  Hilary Longhurst; Marco Cicardi
Journal:  Lancet       Date:  2012-02-04       Impact factor: 79.321

Review 3.  Clinical profile of oxcarbazepine-related angioneurotic edema: case report and review.

Authors:  James F Knudsen; Charlene M Flowers; Cindy Kortepeter; Yasser Awaad
Journal:  Pediatr Neurol       Date:  2007-08       Impact factor: 3.372

4.  Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.

Authors:  Eric Grouzmann; Françoise Livio; Thierry Buclin
Journal:  Hypertension       Date:  2009-07-06       Impact factor: 10.190

5.  Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema.

Authors:  Alencia V Woodard-Grice; Amelia C Lucisano; James B Byrd; Elizabeth R Stone; William H Simmons; Nancy J Brown
Journal:  Pharmacogenet Genomics       Date:  2010-09       Impact factor: 2.089

6.  Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.

Authors:  T Chaudhry; P Hissaria; M Wiese; R Heddle; F Kette; W B Smith
Journal:  Intern Med J       Date:  2012-06       Impact factor: 2.048

7.  Incidence and characteristics of angioedema associated with enalapril.

Authors:  John B Kostis; Harold J Kim; James Rusnak; Thomas Casale; Allen Kaplan; Jonathan Corren; Elliott Levy
Journal:  Arch Intern Med       Date:  2005-07-25

8.  A severe laryngeal angioedema reaction from cefadroxil in a patient with no known allergies to penicillins.

Authors:  G Lamba; V Aswani
Journal:  West Indian Med J       Date:  2011-06       Impact factor: 0.171

9.  Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors.

Authors:  Donald R Miller; Susan A Oliveria; Dan R Berlowitz; Benjamin G Fincke; Paul Stang; David E Lillienfeld
Journal:  Hypertension       Date:  2008-04-14       Impact factor: 10.190

Review 10.  Nonallergic angioedema: role of bradykinin.

Authors:  M Bas; V Adams; T Suvorava; T Niehues; T K Hoffmann; G Kojda
Journal:  Allergy       Date:  2007-08       Impact factor: 13.146

View more
  4 in total

1.  Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study.

Authors:  Karlijn J G Schulkes; Mignon T Van den Elzen; Erik C Hack; Henderikus G Otten; Carla A F M Bruijnzeel-Koomen; André C Knulst
Journal:  Clin Transl Allergy       Date:  2015-02-04       Impact factor: 5.871

Review 2.  Angioedema in the emergency department: a practical guide to differential diagnosis and management.

Authors:  Jonathan A Bernstein; Paolo Cremonesi; Thomas K Hoffmann; John Hollingsworth
Journal:  Int J Emerg Med       Date:  2017-04-13

3.  Hereditary angioedema: how to approach it at the emergency department?

Authors:  Faradiba Sarquis Serpa; Eli Mansour; Marcelo Vivolo Aun; Pedro Giavina-Bianchi; Herberto José Chong Neto; Luisa Karla Arruda; Regis Albuquerque Campos; Antônio Abílio Motta; Eliana Toledo; Anete Sevciovic Grumach; Solange Oliveira Rodrigues Valle
Journal:  Einstein (Sao Paulo)       Date:  2021-04-09

4.  Profile of serious angioedema requiring an urgent advice from a national reference call center.

Authors:  Nicolas Simon; Alexis Bocquet; Isabelle Boccon-Gibod; Laurence Bouillet
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.